双特异性放射性物质 (BRL):两个比一个好
Valeria Bentivoglio1,2, Enrico D'Ippolito1, Pallavi Nayak1
1Nuclear Medicine Unit, Department of Medical-Surgical Sciences and Translational Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
瘤异质性对癌症的诊断和治疗构成挑战. 双特异性放射体提供了一个有希望的分子成像方法来准多个瘤方面,有可能改善患者的结果.
科学领域:
- 癌症学
- 分子成像
- 放射性药物
背景情况:
- 瘤异质性,包括遗传,表观遗传和表型变异性,使癌症诊断和治疗复杂化.
- 这种细胞多样性可能导致对治疗的不同反应,导致药物耐药性和复发.
- 瘤异质性是动态的,随着时间的推移或治疗等刺激而发生变化.
研究的目的:
- 对瘤学分子成像的双特异性放射体 (BRL) 的体外和体内研究进行审查.
- 评估BRL与传统单射药物在治疗瘤异质性的潜在优势.
主要方法:
- 对涉及双特异性放射性体的体外和体内研究进行审查.
- 对识别瘤细胞变化的分子成像技术的分析.
- 放射性药物设计,合成和表征的评估.
主要成果:
- 具有双重向能力的双特异性放射性链体 (BRL) 已成为一种新型放射性药物.
- 这些BRL显示了瘤学分子成像的潜力.
- 研究表明,BRL可能比单一向药物具有优势.
结论:
- 双特异性放射体代表了瘤学分子成像的有希望的进步.
- 它们的双重准能力可能有助于克服瘤异质性带来的挑战.
- 进一步研究和开发BRL可以提高癌症诊断,预后和个性化治疗策略.
更多相关视频
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10:19Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
相关概念视频
Biological Effects of Radiation
Sex Linked Disorders
Dual Nature of Electromagnetic (EM) Radiation
Wavelength is the distance between two consecutive peaks (the highest point) or troughs (the lowest point) in the wave. Frequency is the number of...
Double Resonance Techniques: Overview
Spin decoupling is usually achieved by...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Other Unique Bacteria
